Sex and HDAC4 Differently Affect the Pathophysiology of Amyotrophic Lateral Sclerosis in SOD1-G93A Mice.
ALS
neurogenic muscle atrophy
transgenic mice
velocity of weight loss
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
21 Dec 2022
21 Dec 2022
Historique:
received:
14
11
2022
revised:
16
12
2022
accepted:
18
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
11
1
2023
Statut:
epublish
Résumé
Amyotrophic Lateral Sclerosis (ALS) is a devastating adult-onset neurodegenerative disease, with ineffective therapeutic options. ALS incidence and prevalence depend on the sex of the patient. Histone deacetylase 4 (HDAC4) expression in skeletal muscle directly correlates with the progression of ALS, pointing to the use of HDAC4 inhibitors for its treatment. Contrarily, we have found that deletion of HDAC4 in skeletal muscle worsened the pathological features of ALS, accelerating and exacerbating skeletal muscle loss and negatively affecting muscle innervations in male SOD1-G93A (SOD1) mice. In the present work, we compared SOD1 mice of both sexes with the aim to characterize ALS onset and progression as a function of sex differences. We found a global sex-dependent effects on disease onset and mouse lifespan. We further investigated the role of HDAC4 in SOD1 females with a genetic approach, and discovered morpho-functional effects on skeletal muscle, even in the early phase of the diseases. The deletion of HDAC4 decreased muscle function and exacerbated muscle atrophy in SOD1 females, and had an even more dramatic effect in males. Therefore, the two sexes must be considered separately when studying ALS.
Identifiants
pubmed: 36613534
pii: ijms24010098
doi: 10.3390/ijms24010098
pmc: PMC9820722
pii:
doi:
Substances chimiques
Histone Deacetylases
EC 3.5.1.98
Superoxide Dismutase
EC 1.15.1.1
Superoxide Dismutase-1
EC 1.15.1.1
Hdac5 protein, mouse
EC 3.5.1.98
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Governo Italiano
ID : RBFR12BUMH
Organisme : Sapienza University of Rome
ID : AR120172839F7670
Références
Gend Med. 2012 Dec;9(6):524-35
pubmed: 23217569
J Am Heart Assoc. 2022 May 3;11(9):e024947
pubmed: 35470690
Behav Brain Res. 2010 Nov 12;213(1):82-7
pubmed: 20450936
Science. 1994 Jun 17;264(5166):1772-5
pubmed: 8209258
Sci Rep. 2017 Aug 25;7(1):9538
pubmed: 28842714
JCI Insight. 2021 Jun 8;6(11):
pubmed: 33974561
EBioMedicine. 2019 Feb;40:717-732
pubmed: 30713114
Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Mar;6(1):55-62
pubmed: 16036427
Brain Res. 2011 Jun 7;1394:90-104
pubmed: 21354109
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):666-673
pubmed: 30630957
Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar;2(1):23-9
pubmed: 11465929
Neurology. 2017 Oct 10;89(15):1633-1642
pubmed: 28916533
Brain. 2013 Aug;136(Pt 8):2359-68
pubmed: 23824486
Rev Neurol (Paris). 2020 May;176(5):301-315
pubmed: 32147204
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
J Neurol Sci. 2005 Sep 15;236(1-2):1-7
pubmed: 16024047
Eat Weight Disord. 2021 Feb;26(1):27-35
pubmed: 31865598
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1339-1359
pubmed: 35170869
Amyotroph Lateral Scler. 2012 Oct;13(6):585-8
pubmed: 22873563
J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):867-875
pubmed: 32576612
J Neurol Sci. 2008 May 15;268(1-2):40-7
pubmed: 18054961
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):433-42
pubmed: 17563461
J Neurol. 2019 Jun;266(6):1412-1420
pubmed: 30868220
Mycoses. 2022 Jun;65(6):599-612
pubmed: 35484713
Elife. 2022 Mar 15;11:
pubmed: 35287794
Sci Rep. 2022 Feb 3;12(1):1826
pubmed: 35115598
Nature. 1993 Jul 22;364(6435):362
pubmed: 8332197
Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Jun;3(2):55-6
pubmed: 12215225
EBioMedicine. 2021 Dec;74:103732
pubmed: 34864363
Gend Med. 2010 Dec;7(6):557-70
pubmed: 21195356
Amyotroph Lateral Scler. 2012 Jun;13(4):363-6
pubmed: 22632442
Skelet Muscle. 2018 Feb 24;8(1):6
pubmed: 29477142
Stroke. 2022 May;53(5):1500-1509
pubmed: 35468000
Neuromuscul Disord. 2003 Nov;13(9):737-43
pubmed: 14561497